Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page
- Check5 days agoChange DetectedA consolidated 'Locations' section now lists study sites in Florida, Illinois, Massachusetts, and New York, replacing the previous separate 'Florida Locations', 'Illinois Locations', 'Massachusetts Locations', and 'New York Locations' subsections. The footer link to HHS Vulnerability Disclosure has been removed.SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page displays Revision: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check34 days agoChange DetectedPublications note updated to indicate PubMed entries are auto-filled and may not relate to the study, and Revision: v3.3.1 added; older wording and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check41 days agoChange DetectedThe site-wide funding-status notice about potential delays and operating status has been removed. The message previously directed users to the NIH Clinical Center and OPM for status updates.SummaryDifference0.4%

- Check55 days agoChange DetectedTwo screenshots show only superficial UI updates (layout and last-updated timestamps). Core study details such as eligibility, outcomes, and status appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedUpgrade the page from v3.0.2 to v3.2.0; core content and critical data are unchanged.SummaryDifference0.1%

Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.